In silico analysis of structural and functional consequences in p16INK4A by deleterious nsSNPs associated CDKN2A gene in malignant melanoma

Biochimie

Volumn 90, Issue 10, 2008, Pages 1523-1529

  Rajasekaran, R ^a   Priya Doss, C George ^a   Sudandiradoss, C ^a   Ramanathan, K ^a   Sethumadhavan, Rao ^a  

^a VIT UNIVERSITY   (India)

Author keywords

cdk6; CDKN2A gene; Malignant melanoma; p16INK4A; Single nucleotide polymorphism

Indexed keywords

CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ARTICLE; CDKN2A GENE; COMPUTER MODEL; GENE; GENE MUTATION; HUMAN; MELANOMA; NUCLEIC ACID BASE SUBSTITUTION; PROTEIN STABILITY; PROTEIN STRUCTURE; SINGLE NUCLEOTIDE POLYMORPHISM;

COMPUTATIONAL BIOLOGY; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DATABASES, GENETIC; GENES, P16; MELANOMA; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MUTANT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; PROTEIN CONFORMATION; SOFTWARE; UNTRANSLATED REGIONS;

EID: 50949106676     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2008.05.017     Document Type: Article

References (52)

1. Lee J.E., Choi J.H., Lee J.H., and Lee M.G. Gene SNPs and mutations in clinical genetic testing: haplotype-based testing and analysis. Mutat. Res. 573 (2005) 195-204
2. Collins F.S., Brooks L.D., and Chakravarti A. A DNA polymorphism discovery resource for research on human genetic variation. Genome Res. 8 (1998) 1229-1231
3. Lander E.S. The new genomics: global views of biology. Science 274 (1996) 536-539
4. Nussbaum R., McInnes R., and Willard H. Thompson & Thompson Genetics in Medicine. 6th Edition (2001), WB Saunders, Philadelphia
5. Van Deventer S.J. Cytokine and cytokine receptor polymorphisms in infectious disease. Intensive Care Med. 26 (2000) S98-S102
6. Hayward N.K. Genetics of melanoma predisposition. Oncogene 22 (2003) 3053-3062
7. Haluska F.G., and Hodi F.S. Molecular genetics of familial cutaneous melanoma. J. Clin. Oncol. 16 (1998) 670-682
8. Wang Y.L., Uhara H., Yamazaki Y., Nikaido T., and Saida T. Immunohistochemical detection of CDK4 and p16INK4 proteins in cutaneous malignant melanoma. Br. J. Dermatol. 134 (1996) 269-275
9. Sharpless E., and Chin L. The INK4a/ARF locus and melanoma. Oncogene 22 (2003) 3092-3098
10. Bennett D.C. Human melanocyte senescence and melanoma susceptibility genes. Oncogene 22 (2003) 3063-3069
11. Jin X., Nguyen D., Zhang W.W., Kyritsis A.P., and Roth J.A. Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector. Cancer Res. 55 (1995) 3250-3253
12. Fueyo J., Gomez-Manzano C., Yung W.K.A., Clayman G.L., Liu T.J., Bruner J., Levin V.A., and Kyritsis A.P. Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells. Oncogene 12 (1996) 103-110
13. Byeon I.J., Li J., Ericson K., Selby T.L., Tevelev A., Kim H.J., O'Maille P., and Tsai M.D. Tumor suppressor p16INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4. Mol. Cell 1 3 (1998) 421-431
14. Russo A.A., Tong L., Lee J.O., Jeffrey P.D., and Pavletich N.P. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature 395 6699 (1998) 237-243
15. Lux S.E., John K.M., and Bennett V. Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins. Nature 344 (1990) 36-42
16. Greenwald I., and Rubin G.M. Making a difference: the role of cell-cell interactions in establishing separate identities for equivalent cells. Cell 68 (1992) 271-281
17. Bork P. Hundreds of ankyrin-like repeats in functionally diverse proteins: mobile modules that cross phyla horizontally. Proteins 17 4 (1993) 363-374
18. Helps N.R., Barker H.M., Elledge S.J., and Cohen P.T. Protein phosphatase 1 interacts with p53BP2, a protein which binds to the tumour suppressor p53. FEBS Lett. 377 (1995) 295-300
19. Sherry S.T., Ward M.H., Kholodov M., Baker J., Phan L., Smigielski E.M., and Sirotkin K. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29 (2001) 308-311
20. Ramensky V., Bork P., and Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 30 17 (2002) 3894-3900
21. Prokunina L., and Alarcn-Riquelme M.E. Regulatory SNPs in complex diseases: their identification and functional validation. Expert Rev. Mol. Med. 6 10 (2004) 1-15
22. Prokunina L., Castillejo-Lopez C., Oberg F., Gunnarsson I., Berg L., Magnusson V., Brookes A.J., Tentler D., Kristjansdottir H., Grondal G., et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat. Genet. 32 (2002) 666-669
23. Yuan H.-Y., Chiou J.-J., Tseng W.-H., Liu C.-H., Liu C.-K., Lin Y.-J., Wang H.-H., Yao A., Chen Y.-T., and Hsu C.-N. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res. 34 (2006) W635-W641
24. Cavallo A., and Martin A.C. Mapping SNPs to protein sequence and structure data. Bioinformatics 21 8 (2005) 1443-1450
25. Lindahl E., Azuara C., Koehl P., and Delarue M. Nucleic Acids Res. 34 (2006) W52
26. Delarue M., and Dumas P. On the use of low-frequency normal modes to enforce collective movements in refining macromolecular structural models. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 6957-6962
27. Han J.H., Kerrison N., Chothia C., and Teichmann S.A. Divergence of interdomain geometry in two-domain proteins. Structure 14 5 (2006) 935-945
28. Varfolomeev S.D., and Uporov I.V. Bioinformatics and molecular modeling in chemical enzymology. Active sites of hydrolases, Biochemistry. (Mosc.) 67 10 (2002) 1099-1108
29. Champ P.C., and Camacho C.J. FastContact: a free energy scoring tool for protein-protein complex structures. Nucleic Acids Res. 35 (2007) W556-W560
30. Sharma S., Ding F., Nie H., Watson D., Unnithan A., Lopp J., Pozefsky D., and Dokholyan N.V. iFold: a platform for interactive folding simulations of proteins. Bioinformatics 22 21 (2006) 2693-2694
31. Diemand A.V., and Scheib H. iMolTalk: an interactive, internet-based protein structure analysis server. Nucleic Acids Res. 32 (2004) W512-W516
32. Dracopoli N.C., and Fountain J.W. CDKN2 mutations in melanoma. Cancer Surv. 26 (1996) 115-132
33. Smith-Soerensen B., and Hovig E. CDKN2A (p16INK4A) somatic and germline mutations. Hum. Mutat. 7 (1996) 294-303
34. Hayashi N., Sugimoto Y., Tsuchiya E., Ogawa M., and Nakamura Y. Somatic mutations of the MTS (multiple tumor suppressor) 1/CDK4l (cyclin-dependent kinase-4 inhibitor) gene in human primary non-small cell lung carcinomas. Biochem. Biophys. Res. Commun. 202 (1994) 1426-1430
35. Hussussian C.J., Struewing J.P., Goldstein A.M., Higgins P.A.T., Ally D.S., Sheahan M.D., Clark Jr. W.H., Tucker M.A., and Dracopoli N.C. Germline p16 mutations in familial melanoma. Nat. Genet. 8 (1994) 15-21
36. Zhou X., Tarmin L., Yin J., Jiang H.-Y., Suzuki H., Rhyu M.-G., Abraham J.M., and Meltzer S.J. The MTS1 gene is frequently mutated in primary human esophageal tumors. Oncogene 9 (1994) 3737-3741
37. Okamoto A., Hussain S.P., Hagiwara K., Spillare E.A., Rusin M.R., Demetrick D.J., Serrano M., Hannon G.J., Shiseki M., Zariwala M., Xiong Y., Beach D.H., Yokota J., and Harris C.C. Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res. 55 (1995) 1448-1451
38. Walker G.J., Hussussian C.J., Flores J.F., Glendening J.M., Haluska F.G., Dracopoli N.C., Hayward N.K., and Fountain J.W. Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds. Hum. Mol. Genet. 4 (1995) 1845-1852
39. Ranade K., Hussussian C.J., Sikorski R.S., Varmus H.E., Goldstein A.M., Tucker M.A., Serrano M., Hannon G.J., Beach D., and Dracopoli N.C. Mutations associated with familial melanoma impair p16INK4 function. Nat. Genet. 10 (1995) 114-116
40. Borg A., Johannsson U., Johannsson O., Haakansson S., Westerdahl J., Maasbaeck A., Olsson H., and Ingvar C. Novel germline p16 mutation in familial malignant melanoma in southern Sweden. Cancer Res. 56 (1996) 2497-2500
41. Fitzgerald M.G., Harkin D.P., Silva-Arrieta S., Macdonald D.J., Lucchina L.C., Unsal H., O'Neill E., Koh J., Finkelstein D.M., Isselbacher K.J., Sober A.J., and Haber D.A. Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 8541-8545
42. Harland M., Meloni R., Gruis N., Pinney E., Brookes S., Spurr N.K., Frischauf A.-M., Bataille V., Peters G., Cuzick J., Selby P., Bishop D.T., and Bishop J.N. Germline mutations of the CDKN2 gene in UK melanoma families. Hum. Mol. Genet. 6 (1997) 2061-2067
43. Soufir N., Avril M.-F., Chompret A., Demenais F., Bombled J., Spatz A., Stoppa-Lyonnet D., Benard J., and Bressac-De Paillerets B. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. Hum. Mol. Genet. 7 (1998) 209-216
44. Gretarsdottir S., Olafsdottir G.H., and Borg A. Five novel somatic CDKN2/p16 mutations identified in melanoma, glioma and carcinoma of the pancreas. Hum. Mutat. 12 (1998) 212-212
45. Gueran S., Tunca Y., and Imirzalioglu N. Hereditary TP53 codon 292 and somatic P16INK4A codon 94 mutations in a Li-Fraumeni syndrome family. Cancer Genet. Cytogenet. 113 (1999) 145-151
46. Goldstein A.M., Liu L., Shennan M.G., Hogg D., Tucker M.A., and Struewing J.P. A common founder for the V126D CDKN2A mutation in seven North American melanoma-prone families. Br. J. Cancer 85 (2001) 527-530
47. Randerson-Moor J.A., Harland M., Williams S., Cuthbert-Heavens D., Sheridan E., Aveyard J., Sibley K., Whitaker L., Knowles M., Bishop J.N., and Bishop D.T. A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum. Mol. Genet. 10 (2001) 55-62
48. Hewitt C., Lee Wu C., Evans G., Howell A., Elles R.G., Jordan R., Sloan P., Read A.P., and Thakker N. Germline mutation of ARF in a melanoma kindred. Hum. Mol. Genet. 11 (2002) 1273-1279
49. Ruiz A., Puig S., Malvehy J., Lazaro C., Lynch M., Gimenez-Arnau A.M., Puig L., Sanchez-Conejo J., Estivill X., and Castel T. CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia. J. Med. Genet. 36 (1999) 490-493
50. Hearle N., Damato B.E., Humphreys J., Wixey J., Green H., Stone J., Easton D.F., and Houlston R.S. Contribution of germline mutations in BRCA2, P16(INK4A), P14(ARF) and P15 to uveal melanoma. Invest. Ophthalmol. Vis. Sci. 44 (2003) 458-462
51. Avbelj M., Hocevar M., Trebusak-Podkrajsek K., Krzisnik C., and Battelino T. A novel L94Q mutation in the CDKN2A gene in a melanoma kindred. Melanoma Res. 13 (2003) 567-570
52. Ruas M., Brookes S., McDonald N.Q., and Peters G. Functional evaluation of tumour-specific variants of p16INK4a/CDKN2A: correlation with protein structure information. Oncogene 18 39 (1999) 5423-5434